Inventor · disambiguated record
Tohru Miyazaki
Also filed as: MIYAZAKI TOHRU
21 granted patents·4 pending applications·284 citations·filing 1988–2025
95Inventor score
Top patents by PatentIndex Score
25 records- 0197US10428023B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Oct 1, 2019·22 cites·1 claims
- 0296US10584097B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Mar 10, 2020·14 cites·1 claims
- 0395US11028048B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jun 8, 2021·8 cites·9 claims
- 0494US11440883B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Sep 13, 2022·3 cites·1 claims
- 0593US5710153ATetrazole compoundONO PHRAMACEUTICAL CO LTD·Filed 1996·Granted Jan 20, 1998·112 cites·12 claims
- 0690US6376484B1Tetrazole compounds and pharmaceutical agents containing such derivative as an active ingredientONO PHARMACEUTICAL CO·Filed 2000·Granted Apr 23, 2002·25 cites·17 claims
- 0788US10435399B2HDAC6 inhibitory heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Oct 8, 2019·5 cites·17 claims
- 0887US11319286B2Heterocyclic compound and application thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted May 3, 2022·4 cites·10 claims
- 0987US6136834ATetrazole compounds and pharmaceutical agents containing such derivativeONO PHARMACEUTICAL CO·Filed 1996·Granted Oct 24, 2000·41 cites·14 claims
- 1086US2024360080A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1184US11655241B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted May 23, 2023·2 cites·15 claims
- 1280US12421188B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2025·Granted Sep 23, 2025·0 cites·19 claims
- 1380US12415782B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2025·Granted Sep 16, 2025·0 cites·19 claims
- 1480US12404237B2Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivativesTAKEDA PHARMACEUTICALS CO·Filed 2025·Granted Sep 2, 2025·0 cites·19 claims
- 1577US5168101ASulfonamide derivativesONO PHARMACEUTICAL CO·Filed 1988·Granted Dec 1, 1992·14 cites·6 claims
- 1676US2023063805A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 1775US2021276949A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1874US6177466B1Sulfonylamino acid derivativesONO PHARMACEUTICAL CO·Filed 1996·Granted Jan 23, 2001·18 cites·6 claims
- 1967US6022893AHydroxamic acid derivativesONO PHARMACEUTICAL CO·Filed 1996·Granted Feb 8, 2000·14 cites·6 claims
- 2059US6403644B1Method of treating disease with sulfonylamino acid derivativesONO PHARMACEUTICAL CO·Filed 2000·Granted Jun 11, 2002·2 cites·8 claims
- 2153US12077522B2Heterocyclic compound and application thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 3, 2024·0 cites·11 claims
- 2252US12091410B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 17, 2024·0 cites·13 claims
- 2351US12071434B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Aug 27, 2024·0 cites·14 claims
- 2449US12084436B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Sep 10, 2024·0 cites·16 claims
- 2535US2003130326A11,3,4-oxadiazole derivatives and process for producing the sameFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tohru Miyazaki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →